The pharmaceutical development technology provider has received funding from investors including Google and series A backer Tencent.
China-based drug discovery platform developer XtalPi has closed a series B round backed by internet group Tencent and internet technology provider Google at $15m.
The round, which was led by Sequoia China, a regional branch of venture capital firm Sequoia Capital, increased XtalPi’s total funding to more than $20m.
Founded in 2014, XtalPi has built a computer-based platform that uses quantum physics, artificial intelligence (AI) and cloud processing to model the attributes of small-molecule drugs and other solid forms, helping…
